Target intelligence / Profile preview

microRNA 3910-1 (MIR3910-1)

Target
MIR3910-1
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

microRNA 3910-1 (MIR3910-1) is a small non-coding RNA molecule of approximately 22–24 nucleotides, classified as a human microRNA involved in RNA silencing and post-transcriptional regulation of gene expression. Like other microRNAs, MIR3910-1 acts by binding to partially complementary sequences in the 3' untranslated regions of specific target mRNAs, promoting their degradation or inhibiting their translation. It has been implicated in modulating signaling pathways relevant to cancer: notably, miR-3910 can activate Yes-associated protein (YAP) signaling by targeting and suppressing MST1, thereby promoting the growth and migration of hepatocellular carcinoma cells. While it has not been established as a direct therapeutic target or drug receptor, alterations in MIR3910-1 expression may serve as molecular biomarkers in cancer classification and possibly for patient selection in future therapeutic approaches. More broadly, abnormalities in miRNA expression—including MIR3910-1—have been linked with tumorigenesis, cell proliferation, and other disease processes, reflecting a key regulatory function in cellular homeostasis.

Other names
hsa-mir-3910-1mir-3910-1MIR3910-1
02

Mechanism of action

Not a classical drug target; mechanistically, MIR3910-1 operates by binding to the 3'-untranslated region (3'-UTR) of its target mRNAs, causing mRNA degradation or translational repression

03

Biological functions

Gene regulation via post-transcriptional silencingRegulation of mRNA stability and translationModulation of cellular signaling pathways
04

Disease associations

Cancer (with evidence for a role in hepatocellular carcinoma)Other (given general microRNA dysregulation associations with diverse diseases)
05

Safety considerations

None directly reported; general challenges of miRNA-based interventions include off-target effects and broad network consequences
06

Interacting drugs

None known
07

Biomarkers

Potential as a biomarker for hepatocellular carcinoma and possibly other cancers (based on general microRNA biomarker utility)

Beyond the preview

Go deeper on microRNA 3910-1 (MIR3910-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 3910-1 (MIR3910-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call